StabiLux Biosciences
US-based StabiLux Biosciences produces dyes, enhancing research detection capabilities with existing equipment.
Founded
2014US-based StabiLux Biosciences produces dyes, enhancing research detection capabilities with existing equipment.
Founded in Houghton, United States, StabiLux Biosciences is dedicated to advancing scientific research through innovative dye technology. Their core mission is to enhance detection capabilities in research, making previously undetectable elements visible. The company's vision is to empower researchers by maximizing the potential of existing laboratory equipment without requiring additional parts or new software. StabiLux offers a drop-in platform technology that integrates seamlessly with current systems, providing a cost-effective and efficient solution for the scientific community.
StabiLux Biosciences has garnered attention from notable investors and industry experts, contributing to its rapid growth and recognition in the biotech sector. The company's key achievements include the successful development and commercialization of their advanced dye technology, which has been widely adopted by research institutions. StabiLux's impact is evident in the enhanced accuracy and efficiency of scientific experiments, ultimately accelerating discoveries and innovations across various fields of study.
Companies similar to StabiLux Biosciences include Sharp Edge Labs, Stablix, Nirvana Sciences and Enzium.
StabiLux Biosciences was founded in 2014.
StabiLux Biosciences' headquarters is located in Houghton, MI, US.
StabiLux Biosciences' most recent funding round was for $276k (USD) in September 2020.
As of Sep 2, 2020, StabiLux Biosciences has disclosed funding of $1.9M (USD). Undisclosed round amounts are excluded.
StabiLux Biosciences has 14 employees as of Feb 4, 2024.
enziumlabs.com
